Canada markets closed

ATRA Sep 2024 0.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
As of 01:01PM EDT. Market open.
Full screen
Previous Close0.2000
Open0.2000
Bid0.1000
Ask0.4000
Strike0.50
Expire Date2024-09-20
Day's Range0.2000 - 0.2000
Contract RangeN/A
Volume6
Open Interest1.01k
  • GlobeNewswire

    Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

    MIAMI, June 12, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 72nd Emerging Growth Conference on June 12 & 13, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani

  • Business Wire

    Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    THOUSAND OAKS, Calif., June 07, 2024--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of 9,700 restricted stock units of Atara’s common stock to one newly hired employee. This award was approved by the Compensation Committee of Atara’s Board of Directors and granted under the Atara Bio

  • Business Wire

    Atara Biotherapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

    THOUSAND OAKS, Calif., June 05, 2024--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief Executive Officer and Cokey Nguyen, Ph.D., Executive Vice President, Chief Scientific & Technical Officer, will participate in a fireside chat at the Goldman Sachs 45th